Last reviewed · How we verify

NCT04438356

M-Health Care for Patients After AMI on Disease Perception, Self-Efficacy, Anxiety and Cardio-Respiratory Fitness

Completed NA Last updated 28 September 2022
What this trial tests

NA trial testing M-Health in Mobile Health in 31 participants. Completed in 20 March 2022.

Timeline
22 July 2020
Primary endpoint
20 March 2022
20 March 2022

Quick facts

Lead sponsorNational Defense Medical Center, Taiwan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment31
Start date22 July 2020
Primary completion20 March 2022
Estimated completion20 March 2022
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Defense Medical Center, Taiwan

Who can join

20 and older, any sex, with Mobile Health or Acute Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to explore the overall effectiveness of interventions using mobile health care to improve disease perception, self-efficacy, anxiety, cardio-pulmonary fitness for patients with acute myocardial infarction.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Exercise-based cardiac rehabilitation for coronary heart disease.
    Dibben G, Faulkner J, Oldridge N, Rees K, et al · · 2021 · cited 323× · PMID 34741536 · DOI 10.1002/14651858.cd001800.pub4

Verify or expand the search:

Other recruiting trials for Mobile Health

Currently open trials in the same condition.

Other National Defense Medical Center, Taiwan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04438356.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing